![1]()
News
FDA okays emergency use of convalescent plasma for seriously ill COVID-19 patients
March 28, 2020
“It’s crucial that data be captured for every patient so that we really understand what safety and effectiveness looks like on as close to a real-world level as we can, as quickly as we can,” said Peter J. Pitts, a former associate commissioner of the FDA.
News
Webinar confronts unique issues for the bleeding disorders community facing COVID-19
March 23, 2020
Patients in gene therapy trials and those with factor inhibitors are of particular concern.
![1]()
News
DOACs for treatment of cancer-associated venous thromboembolism
January 23, 2020
Recent studies suggest DOACs may be a viable option in the treatment of malignancy-associated VTE.
![1]()
News
New ASH guideline: VTE prophylaxis after major surgery
December 12, 2019
ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the American Society of Hematology.
![1]()
News
Aspirin plus a DOAC may do more harm than good in some
December 8, 2019
Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication increased bleeding risks in a large cohort.
![1]()
News
Transfusion-related lung injury is on the rise in elderly patients
November 14, 2019
SAN ANTONIO – Researchers at the Food and Drug Administration examined trends in potentially life-threatening or fatal transfusion-related adverse events in patients aged 65 years and older.
![1]()
News
Dose-reduced NOACs may be safer than warfarin in some AFib patients
October 31, 2019
Are dose-reduced non–vitamin K antagonist oral anticoagulants (NOACs) safer or more effective than warfarin is in patients with atrial fibrillation who are eligible for a dose-reduced NOAC?
![1]()
News
Updated international consensus recommendations on management of acute upper GI bleeding
October 21, 2019
Updated guidelines on management of nonvariceal acute upper GI bleeding address questions on endoscopic techniques and pharmacologic management.
![1]()
News
FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients
October 15, 2019
The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.
![1]()
News
Is it safe to discharge patients with anemia?
September 23, 2019
What is the prevalence of anemia at the time of and after discharge from the hospital, and what is the associated morbidity and mortality at 6 months?
